These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 27497989
1. Cell-specific paracrine actions of IL-6 family cytokines from bone, marrow and muscle that control bone formation and resorption. Sims NA. Int J Biochem Cell Biol; 2016 Oct; 79():14-23. PubMed ID: 27497989 [Abstract] [Full Text] [Related]
2. Regulation of cortical and trabecular bone mass by communication between osteoblasts, osteocytes and osteoclasts. Sims NA, Vrahnas C. Arch Biochem Biophys; 2014 Nov 01; 561():22-8. PubMed ID: 24875146 [Abstract] [Full Text] [Related]
3. Talking among ourselves: paracrine control of bone formation within the osteoblast lineage. Tonna S, Sims NA. Calcif Tissue Int; 2014 Jan 01; 94(1):35-45. PubMed ID: 23695526 [Abstract] [Full Text] [Related]
4. Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone. Johnson RW, McGregor NE, Brennan HJ, Crimeen-Irwin B, Poulton IJ, Martin TJ, Sims NA. Bone; 2015 Dec 01; 81():343-351. PubMed ID: 26255596 [Abstract] [Full Text] [Related]
5. Influences of the IL-6 cytokine family on bone structure and function. Sims NA. Cytokine; 2021 Oct 01; 146():155655. PubMed ID: 34332274 [Abstract] [Full Text] [Related]
6. Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone. Richards CD, Langdon C, Deschamps P, Pennica D, Shaughnessy SG. Cytokine; 2000 Jun 01; 12(6):613-21. PubMed ID: 10843736 [Abstract] [Full Text] [Related]
7. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. Bellido T, Stahl N, Farruggella TJ, Borba V, Yancopoulos GD, Manolagas SC. J Clin Invest; 1996 Jan 15; 97(2):431-7. PubMed ID: 8567964 [Abstract] [Full Text] [Related]
8. Autocrine and Paracrine Regulation of the Murine Skeleton by Osteocyte-Derived Parathyroid Hormone-Related Protein. Ansari N, Ho PW, Crimeen-Irwin B, Poulton IJ, Brunt AR, Forwood MR, Divieti Pajevic P, Gooi JH, Martin TJ, Sims NA. J Bone Miner Res; 2018 Jan 15; 33(1):137-153. PubMed ID: 28914969 [Abstract] [Full Text] [Related]
9. Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling. Guihard P, Danger Y, Brounais B, David E, Brion R, Delecrin J, Richards CD, Chevalier S, Rédini F, Heymann D, Gascan H, Blanchard F. Stem Cells; 2012 Apr 15; 30(4):762-72. PubMed ID: 22267310 [Abstract] [Full Text] [Related]
10. The cytokine interleukin-11 crucially links bone formation, remodeling and resorption. Kespohl B, Schumertl T, Bertrand J, Lokau J, Garbers C. Cytokine Growth Factor Rev; 2021 Aug 15; 60():18-27. PubMed ID: 33940443 [Abstract] [Full Text] [Related]
11. The primary function of gp130 signaling in osteoblasts is to maintain bone formation and strength, rather than promote osteoclast formation. Johnson RW, Brennan HJ, Vrahnas C, Poulton IJ, McGregor NE, Standal T, Walker EC, Koh TT, Nguyen H, Walsh NC, Forwood MR, Martin TJ, Sims NA. J Bone Miner Res; 2014 Jun 15; 29(6):1492-505. PubMed ID: 24339143 [Abstract] [Full Text] [Related]
12. Osteoimmunology: oncostatin M as a pleiotropic regulator of bone formation and resorption in health and disease. Sims NA, Quinn JM. Bonekey Rep; 2014 Jun 15; 3():527. PubMed ID: 24876928 [Abstract] [Full Text] [Related]
13. Myokines (muscle-derived cytokines and chemokines) including ciliary neurotrophic factor (CNTF) inhibit osteoblast differentiation. Johnson RW, White JD, Walker EC, Martin TJ, Sims NA. Bone; 2014 Jul 15; 64():47-56. PubMed ID: 24721701 [Abstract] [Full Text] [Related]
14. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation. Standal T, Johnson RW, McGregor NE, Poulton IJ, Ho PW, Martin TJ, Sims NA. J Endocrinol; 2014 Nov 15; 223(2):181-90. PubMed ID: 25228504 [Abstract] [Full Text] [Related]
15. IL-6 exhibits both cis- and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis. McGregor NE, Murat M, Elango J, Poulton IJ, Walker EC, Crimeen-Irwin B, Ho PWM, Gooi JH, Martin TJ, Sims NA. J Biol Chem; 2019 May 10; 294(19):7850-7863. PubMed ID: 30923130 [Abstract] [Full Text] [Related]
16. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density. Gradin P, Hollberg K, Cassady AI, Lång P, Andersson G. Cells Tissues Organs; 2012 May 10; 196(1):68-81. PubMed ID: 22248481 [Abstract] [Full Text] [Related]
17. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice. Cheon YH, Kim JY, Baek JM, Ahn SJ, Jun HY, Erkhembaatar M, Kim MS, Lee MS, Oh J. J Bone Miner Res; 2016 Feb 10; 31(2):403-15. PubMed ID: 26255791 [Abstract] [Full Text] [Related]
18. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption. Neale SD, Sabokbar A, Howie DW, Murray DW, Athanasou NA. J Orthop Res; 1999 Sep 10; 17(5):686-94. PubMed ID: 10569477 [Abstract] [Full Text] [Related]
19. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro. Saleh H, Eeles D, Hodge JM, Nicholson GC, Gu R, Pompolo S, Gillespie MT, Quinn JM. Endocrinology; 2011 May 10; 152(5):1911-22. PubMed ID: 21363931 [Abstract] [Full Text] [Related]
20. Molecular mechanisms in coupling of bone formation to resorption. Martin T, Gooi JH, Sims NA. Crit Rev Eukaryot Gene Expr; 2009 May 10; 19(1):73-88. PubMed ID: 19191758 [Abstract] [Full Text] [Related] Page: [Next] [New Search]